Dilek Colak

In collaboration with regional and international partners, we address critical health challenges that disproportionately affect our population. Cancer remains a major research priority, as Arab patients are often diagnosed at a younger age and present with more aggressive disease. Despite this, Arab population data remain significantly underrepresented in global multi-omics research.

Our research seeks to address these issues, while also investigating other complex diseases, such as idiopathic cardiomyopathy and infection-associated lung injury in transplant donors. Through these projects, we aim to define molecular disease signatures, develop robust biomarkers, and improve diagnostics, prognostic, and therapeutic strategies across multiple clinical specialties.